Cadent Therapeutics

Acquired

Cadent Therapeutics is a biotech company in Cambridge, United States, founded in 2017. It has raised $40.0M across 1 round, most recently a $40.0M Series B in November 2018.

Employees
11–50
Founded
2017
Business Model
B2B
Total Funding
$40.0M
Last Round
$40.0M Series BNov 2018
Rounds
1
Acquired by
Novartis AGJan 2021 · $770.0M

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 6 investors for this company. The full record is or through the API.

About

Cadent Therapeutics was a Cambridge, Massachusetts-based neuroscience company that developed novel therapies targeting NMDA receptors for neurological and psychiatric conditions, including schizophrenia, movement disorders, and treatment-resistant depression. The company was founded in early 2017 through a merger of Luc Therapeutics and Ataxion, and built a pipeline of clinical-stage assets including CAD-9303 (schizophrenia, Phase 1), CAD-1883 (movement disorders, Phase 2), and MIJ821 (treatment-resistant depression). Cadent was acquired by Novartis in a deal announced December 17, 2020 and closed in Q1 2021.

Summary

It lists 11–50 employees. It has raised $40.0M in total across 1 round, most recently a $40.0M Series B round in Nov 2018. Investors include Novartis Venture Fund, Cowen Healthcare Investments and Atlas Venture.

Funding & Exit History

Data from Indexed.vcUpdated
AcquisitionJan 2021

Sign up to see all 2 events

Funding: Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Cadent Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/cadent-therapeutics"><img src="https://indexed.vc/api/badge/company/cadent-therapeutics" alt="Cadent Therapeutics on Indexed.vc" width="260" height="76" /></a>